PRP Intrauterine Infusion in Thawed Embryo Cycles

Evaluations Clinical Trial

Official title:
Intrauterine Infusion of Platelet-rich Plasma Infusion Before Thawed Embryo Transfer in Repeated Implantation Failure: A Randomized Controlled Study

Status Completed

Clinical Trial Summary

All patients prepared to thawed embryo transfer were classified into 2 groups one group will receive platelet rich plasma (PRP) infusion intrauterine and the other group will not receive platelet rich plasma (PRP) infusion

Clinical Trial Description

Patients candidates for Thawed embryo transfer with Repeated implantation failure were recruited from 3 centers and classified into 2 groups: Group I: Will receive platelet rich plasma (PRP) intrauterine infusion at day 11 Group II: Not receiving platelet rich plasma (PRP) ;

Study Design

Related Conditions & MeSH terms

Evaluations

Clinical Trial Details

NCT number	NCT03734042
Study type	Interventional
Source	Tanta University
Contact
Status	Completed
Phase	Phase 4
Start date	December 1, 2018
Completion date	October 31, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05365698` - Supporting Optimal Infant, Young Child and Maternal Nutrition and Health in Jordan: An Evaluation of the CHN Program
Active, not recruiting	`NCT03964311` - Risk for Short-term Adverse Events in Older Emergency Department Users	N/A
Recruiting	`NCT05381233` - Quality of Life and Functional Performance in Children With Spastic Cerebral Palsy	N/A
Completed	`NCT03286660` - 3 Minutes Chair Rise Test (3CRT) in Patients With COPD	N/A